Emerging Medication in Australia: A Potential Breakthrough for Obesity Management ?
Australia is currently observing the arrival of retatrutide, a cutting-edge dual GIP and GLP-1 receptor medication , representing a exciting advance in addressing excess weight. Early clinical trials have demonstrated impressive results, showing greater effectiveness than existing treatments like